Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02023346

Enrollment

Registered

2013-12-30

Start date

2013-12-31

Completion date

2018-10-30

Last updated

2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Glioma

Keywords

Patient-Physician Communication, Brain cancer, 13-253

Brief summary

The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.

Interventions

BEHAVIORALsurveys and cognitive tests

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Patient Inclusion Criteria * Age greater than or equal to 18 * Diagnosis of any WHO grade III or IV glioma * Admitted to the inpatient Neurology service * Has had at least one outpatient visit with a neuro-oncologist at MSKCC Fluent in English Caregiver Inclusion Criteria * Age greater than or equal to 18 * Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her physical or emotional assistance. * The patient has himself or herself agreed to participate in this study

Exclusion criteria

Patient

Design outcomes

Primary

Measure	Time frame	Description
measure prognostic awareness	2 years	Prognostic awareness (PA) will be measured using the Chochinov Prognostic Awareness Scale. This scale classifies patients into three categories of awareness: full, limited, or no awareness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026